Valneva Says Now That The Covid Vaccine Development Is Behind Us, We Are Reactivating Our Zika Program; We Believe There Is A Significant Unmet Medical Need And We See A Highly Complementary Potential Asset
Portfolio Pulse from Benzinga Newsdesk
Valneva has announced that it is reactivating its Zika program, now that the development of its Covid vaccine is complete. The company believes there is a significant unmet medical need and sees a highly complementary potential asset in the Zika program.
September 21, 2023 | 1:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Valneva's decision to reactivate its Zika program could potentially lead to a new revenue stream for the company, if the program is successful.
Valneva's reactivation of its Zika program indicates the company's confidence in the potential success of this program. If successful, this could lead to a new product and revenue stream for the company, which would likely have a positive impact on the company's stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100